We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GOP Senators Urge FDA Adcomms to Reconsider Evaluations of Life-Saving Drugs
GOP Senators Urge FDA Adcomms to Reconsider Evaluations of Life-Saving Drugs
Two GOP senators are sounding off on the FDA over an advisory committee recommendation against Sarepta’s Duchenne muscular dystrophy treatment eteplirsen.